Araceli Biosciences

Tigard, United States

Araceli Biosciences is a developer of scientific tools for tissue and cell-based biomarker discovery, drug discovery, and drug development.

$12.2M raised

Apr 2025

Seed

Biotechnology Medical Medical Device

Top Investors

Bill Cortelyou

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Araceli Biosciences

How much funding has Araceli Biosciences raised?

Araceli Biosciences has raised $12.2M in total funding. The most recent round was Seed. The last funding was announced in April 2025.

Who are Araceli Biosciences's investors?

Araceli Biosciences's investors include Bill Cortelyou.

Where is Araceli Biosciences headquartered?

Araceli Biosciences is headquartered in Tigard, United States.

What does Araceli Biosciences do?

Araceli Biosciences is a developer of scientific tools for tissue and cell-based biomarker discovery, drug discovery, and drug development.

What stage is Araceli Biosciences at?

Araceli Biosciences is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 24, 2025.

MLA

"Araceli Biosciences — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/araceli-biosciences. Accessed July 2, 2026.

APA

VCBacked. (2025). Araceli Biosciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/araceli-biosciences

Wikipedia (cite web)

{{cite web |title=Araceli Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/araceli-biosciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 24, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K